Study Title and Description
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Key Questions Addressed
|9||Key Question 9. What is the association between experiencing SVR following antiviral treatment and reduction in risk of HCV-related adverse health outcomes?|
Primary Publication Information
|Title||Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.|
|Author||Tateyama M., Yatsuhashi H., Taura N., Motoyoshi Y., Nagaoka S., Yanagi K., Abiru S., Yano K., Komori A., Migita K., Nakamura M., Nagahama H., Sasaki Y., Miyakawa Y., Ishibashi H.|
|Country||Clinical Research Center, National Nagasaki Medical Center, Nagasaki, 856-8562, Japan.|
Pubmed ID: 20711614
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-9
Results & Comparisons
No Results found.